Tyche Industries Ltd
NSE: BSE: 532384
₹99.80
(-4.22%)
Fri, 10 Apr 2026, 03:25 am
Market Cap1.02B
PE Ratio15.22
Dividend2.88
Health Technology
Pharmaceuticals: Major
24.5KTyche Industries Analysis
dividend
- Dividends paid are thoroughly covered by earnings (29.2x coverage).
- Dividends per share have been stable in the past 10 years.
- No dividend growth in 10 years.
- Tyche Industries's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
- Tyche Industries's dividend is below the markets top 25% of dividend payers in India (3.08%).
health
- Tyche Industries is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Tyche Industries is profitable, therefore cash runway is not a concern.
- Tyche Industries is profitable, therefore cash runway is not a concern.
- Tyche Industries's cash and other short term assets cover its long term commitments.
- Tyche Industries has no debt, therefore coverage of interest payments is not a concern.
- Operating cash flow is negative therefore debt is not well covered.
- Debt is not covered by short term assets, assets are -1476.2x debt.
- High level of physical assets or inventory.
management
- The tenure for the Tyche Industries board of directors is about average.
- Ganesh's remuneration is lower than average for companies of similar size in India.
- Ganesh's compensation has been consistent with company performance over the past year, both up more than 20%.
misc
- Tyche Industries is not covered by any analysts.
- Tyche Industries has significant price volatility in the past 3 months.
past
- Tyche Industries's 1-year earnings growth exceeds its 5-year average (129.2% vs 36.4%)
- Tyche Industries has delivered over 20% year on year earnings growth in the past 5 years.
- Tyche Industries used its assets more efficiently than the IN Pharmaceuticals industry average last year based on Return on Assets.
- Tyche Industries has significantly improved its use of capital last year versus 3 years ago (Return on Capital Employed).
- Tyche Industries has efficiently used shareholders’ funds last year (Return on Equity greater than 20%).
- Tyche Industries's earnings growth has exceeded the IN Pharmaceuticals industry average in the past year (129.2% vs 22.7%).
value
- Tyche Industries is good value based on earnings compared to the IN Pharmaceuticals industry average.
- Tyche Industries is good value based on earnings compared to the India market.
- 532384 outperformed the Pharmaceuticals industry which returned 26.7% over the past year.
- 532384 outperformed the Market in India which returned -14.5% over the past year.
- Tyche Industries's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).
- Tyche Industries's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).
- Tyche Industries is overvalued based on assets compared to the IN Pharmaceuticals industry average.
- BSE:532384 is flat (-0.6%) underperforming the Pharmaceuticals industry which returned 6.8% over the past month.
- BSE:532384 is flat (-0.6%) underperforming the market in India which returned 8% over the past month.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800